Effects of Virtual Reality on Anxiety, Stress, and Work Performance in ICU Nurses
NCT ID: NCT07097519
Last Updated: 2025-07-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
13 participants
INTERVENTIONAL
2025-03-01
2025-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study aims to evaluate whether an IVR application can reduce anxiety and stress levels while enhancing the job performance of ICU nurses. By introducing a clinical intervention based on virtual reality, the research seeks to explore its potential as a practical tool in improving nurses' well-being and work effectiveness in high-pressure environments. The findings will contribute to understanding the clinical applicability of IVR as a stress-reduction and performance-enhancement method in intensive care settings.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Technological innovations, particularly in virtual reality, offer promising solutions for mental health support and professional development in healthcare. IVR has been used successfully in various healthcare settings to reduce stress, improve coping strategies, and enhance performance. Despite this, no study has yet specifically examined its effect on ICU nurses.
In this randomized controlled trial, participants will be assigned to either an intervention group using the IVR application or a control group receiving standard care. The IVR experience is designed to promote relaxation, reduce psychological strain, and reinforce professional competencies through immersive scenarios. Outcome measures will include validated scales for anxiety, stress, and job performance, collected before and after the intervention.
The ultimate goal of this study is to assess the clinical applicability of IVR technology in supporting ICU nurses' mental well-being and work performance, offering a novel approach to workforce resilience in critical care settings.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Immersive Virtual Reality Intervention for ICU Nurses
Participants in this arm are registered nurses working in an intensive care unit who receive an immersive virtual reality (IVR) intervention. The intervention involves the use of a VR exergame (Beat Saber) through Oculus Quest 2 headsets. Nurses engage in VR sessions for a minimum of 10 minutes per day across 8-16 clinical workdays over an 8-week period. The intervention is designed to reduce anxiety and stress levels and enhance job performance. Outcome measures include anxiety, stress, individual job performance, and satisfaction ratings collected pre- and post-intervention.
Immersive Virtual Reality (IVR)
This intervention involves the use of a high-end immersive virtual reality (IVR) application through the Oculus Quest 2 headset. Nurses participate in a rhythm-based exergame, Beat Saber, for at least 10 minutes per session, during 8-16 clinical shifts over an 8-week period. The game engages users in physical movement to music, requiring whole-body coordination and providing visual, auditory, and haptic feedback. The intervention aims to reduce stress and anxiety and enhance job performance among ICU nurses by providing an immersive, engaging, and therapeutic experience within the clinical environment.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Immersive Virtual Reality (IVR)
This intervention involves the use of a high-end immersive virtual reality (IVR) application through the Oculus Quest 2 headset. Nurses participate in a rhythm-based exergame, Beat Saber, for at least 10 minutes per session, during 8-16 clinical shifts over an 8-week period. The game engages users in physical movement to music, requiring whole-body coordination and providing visual, auditory, and haptic feedback. The intervention aims to reduce stress and anxiety and enhance job performance among ICU nurses by providing an immersive, engaging, and therapeutic experience within the clinical environment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Currently employed as a nurse in the Anesthesia and Reanimation Intensive Care Unit
* Has been working in the unit for at least 3 months
* Able and available to use the virtual reality (VR) application for a minimum of 10 minutes per day
* Willing to use the VR application on 8 to 16 clinical workdays during the 8-week intervention period
Exclusion Criteria
* Physical limitations that prevent movement (e.g., amputation, joint restriction)
* Health problems that interfere with VR use, including chronic pain, hearing or vision loss, migraine, vertigo, nausea, epilepsy, claustrophobia, head injuries, or psychiatric treatment
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul University - Cerrahpasa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Merve BEKE
Phd, Nurse Educator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oncology Hospital
Ankara, Yenimahalle, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-292
Identifier Type: -
Identifier Source: org_study_id